Beyond DevOps: Can System Initiative Finally Deliver on the Promise of Seamless Software Delivery?
cside Joins AWS Partner Network and the ISV Accelerate Program
Veea and Genesys Impact Launch On-Site AI Safety & Asset Intelligence Platform for MCN
IPinfo Expands Google Cloud Marketplace Offering With New IP Products
DTEX Launches First AI-Powered, Risk-Adaptive DLP Solution, Setting a New Standard for Modern Data Protection
Findings Published as Congress Demands Review of Medicare Coverage for Non-opioid Treatments CLEVELAND, April 26,…
Biosplice’s Phase 2b trial for lorecivivint hits primary endpoint in osteoarthritis pain SAN DIEGO, April…
David Baker, President and CEO of Vallon to participate in the virtual Advances in Neuropsychiatry…
LA JOLLA, Calif, April 26, 2021 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (the…
SAN DIEGO, April 26, 2021 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a…
LAS VEGAS, NV, April 26, 2021 (GLOBE NEWSWIRE) — via NewMediaWire ‒ One World Pharma…
NEW YORK, April 26, 2021 (GLOBE NEWSWIRE) — Better Choice Company (OTCQX: BTTR) (“Better Choice”),…
AUSTIN, Texas, April 26, 2021 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage…
BOSTON and CAMBRIDGE, Mass. and ZUG, Switzerland, April 26, 2021 (GLOBE NEWSWIRE) — Vertex Pharmaceuticals…
EWING, N.J., April 26, 2021 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”),…
Non-dilutive capital to support advancement of ADXS-HOT neoantigen program PRINCETON, N.J., April 26, 2021 (GLOBE…
PRESS RELEASE April 26, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on…
Second Biotherapeutic Partnership of 2021 SAN CARLOS, Calif., April 26, 2021 (GLOBE NEWSWIRE) — BioCardia®,…
Vaxart to provide new data from its Phase I COVID-19 trial Stanford University T-cell expert…
SOUTH SAN FRANCISCO, Calif., April 26, 2021 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic…
RAMSEY, N.J. and BOCA RATON, Fla. and GOOSE CREEK, S.C., April 26, 2021 (GLOBE NEWSWIRE)…
NEW YORK, April 26, 2021 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company…
– Company Establishes Agreement with Worldwide Clinical Trials to Conduct PK Study – – Anticipates initiating PK…
SOUTH SAN FRANCISCO, Calif., April 26, 2021 (GLOBE NEWSWIRE) — Fountain Therapeutics, a biopharmaceutical company…
New Gateway Test and Measurement Guidelines and White Paper on Radio Coexistence Issues and Solutions…